{"version":"1.0","provider_name":"Sequana Medical","provider_url":"https:\/\/www.sequanamedical.com\/nl\/","title":"Transparantiekennisgeving van Aandeelhouders - Sequana Medical","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"qAFLowqmES\"><a href=\"https:\/\/www.sequanamedical.com\/nl\/persberichten\/transparantiekennisgeving-van-aandeelhouders-15\/\">Transparantiekennisgeving van Aandeelhouders<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.sequanamedical.com\/nl\/persberichten\/transparantiekennisgeving-van-aandeelhouders-15\/embed\/#?secret=qAFLowqmES\" width=\"600\" height=\"338\" title=\"&#8220;Transparantiekennisgeving van Aandeelhouders&#8221; &#8212; Sequana Medical\" data-secret=\"qAFLowqmES\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.sequanamedical.com\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","description":"Gent, Belgi\u00eb \u2013 17 december 2025 \u2013 Sequana Medical NV (Euronext Brussels: SEQUA) (de &#8220;Vennootschap&#8221; of &#8220;Sequana Medical&#8221;), een pionier in de behandeling van geneesmiddelresistente vochtoverbelasting in leveraandoeningen, hartfalen en kanker, kondigt vandaag aan dat zij transparantiekennisgevingen heeft ontvangen met betrekking tot de hieronder vermelde entiteiten, met vermelding van het aantal stemrechten verbonden aan de [&hellip;]"}